Our study is in line with these results regarding the MHC/co-receptor match, even if the MHC context and the MHC/co-receptor mismatch are different and these features can influence the capacity of CD4+ and CD8+ TCR-T to eradicate tumor cells. The gene discussed is HLA-C; the disease is neoplasm.